Agilent Adds Breach of Contract to Counterclaims in PerkinElmer Mass Spec Suit | GenomeWeb

PerkinElmer and Agilent Technologies continue to wage their mass spec patent dispute, with defendant Agilent this month winning approval for a motion to expand its counterclaims against PerkinElmer.

Agilent moved to amend its counterclaims to add a count for breach of contract after learning in discovery that in 2010 PerkinElmer granted licenses to its mass spec IP to three other firms on terms, Agilent claimed, that were more favorable than those of Agilent's license to that same IP.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

This Week in Science: New research into the emergence of infectious diseases, and scientists report on proteins involved in melanoma.

The hashtag #stupidcommonnames is gaining fans among scientists who find the common names of some animals and plants dumb.

Fed up with budget slashes, job cuts, and muzzling mandates, researchers in Canada are making science a campaign issue in the upcoming elections.

A former NIH program officer says the Internet has blasted open the door for scientific publications more interested in dollars than quality research.